Gilead Sciences stock falls on potential HIV funding cuts

Published 18/03/2025, 21:20
©  Reuters

Investing.com -- Shares of Gilead Sciences (NASDAQ: NASDAQ:GILD) fell 3.4% following a recent Wall Street Journal report indicating that the Health and Human Services Department is considering significant reductions in federal funding for domestic HIV prevention efforts. This potential policy shift is raising concerns about the impact on Gilead Sciences, a major player in HIV treatment and prevention.

The Wall Street Journal outlined that the proposed funding cuts could be announced imminently, although plans have not been finalized and could still be subject to change. The report comes amid broader discussions about personnel reductions at the Centers for Disease Control and Prevention (CDC), which is facing a reorganization that could exploit gaps in the legal framework defining the agency’s functions and authorizing its programs.

The CDC’s division dedicated to HIV and infectious disease prevention is particularly at risk, as it supports state and local HIV surveillance, syringe services, and community outreach initiatives. In the fiscal year 2023, the CDC allocated approximately $1.3 billion to prevent HIV, viral hepatitis, sexually transmitted infections, and tuberculosis, according to the agency’s website.

The Health Department has stated that it is adhering to the administration’s guidance and scrutinizing all divisions for potential overlaps that could be consolidated. This is part of a larger effort to restructure the federal government. A spokesperson for the department emphasized that no definitive decision regarding the streamlining of the CDC’s HIV Prevention Division has been made. Meanwhile, the CDC and the White House have not immediately responded to requests for comments on the matter.

Investors are closely monitoring the situation, as changes to government funding for HIV prevention could have significant implications for companies like Gilead Sciences that are deeply involved in the sector. The potential policy changes reflect a broader push within the current administration to reorganize and potentially downsize various government departments and programs.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.